Boundless Bio Common Stock Technical Analysis
| BOLD Stock | USD 1.26 0.01 0.79% |
As of the 24th of January, Boundless Bio shows the Risk Adjusted Performance of (0.05), standard deviation of 2.95, and Mean Deviation of 2.12. Boundless Bio Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Boundless Bio Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Boundless Bio Common is priced correctly, providing market reflects its regular price of 1.26 per share. Given that Boundless Bio is a hitting penny stock territory we recommend to closely look at its jensen alpha.
Boundless Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Boundless, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BoundlessBoundless | Build AI portfolio with Boundless Stock |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Boundless Bio Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio's value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio's market value can be influenced by many factors that don't directly affect Boundless Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Boundless Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Boundless Bio on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Boundless Bio Common or generate 0.0% return on investment in Boundless Bio over 90 days. Boundless Bio is related to or competes with Q32 Bio, NextCure, Plus Therapeutics, Intensity Therapeutics, Iterum Therapeutics, AN2 Therapeutics, and Pluri. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 4.13 |
Boundless Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio's standard deviation. In reality, there are many statistical measures that can use Boundless Bio historical prices to predict the future Boundless Bio's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.57) |
Boundless Bio January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.56) | |||
| Mean Deviation | 2.12 | |||
| Coefficient Of Variation | (1,273) | |||
| Standard Deviation | 2.95 | |||
| Variance | 8.73 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.57) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 4.13 | |||
| Skewness | 0.8895 | |||
| Kurtosis | 3.04 |
Boundless Bio Common Backtested Returns
Boundless Bio Common secures Sharpe Ratio (or Efficiency) of -0.0786, which signifies that the company had a -0.0786 % return per unit of risk over the last 3 months. Boundless Bio Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boundless Bio's Mean Deviation of 2.12, risk adjusted performance of (0.05), and Standard Deviation of 2.95 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boundless Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boundless Bio is expected to be smaller as well. At this point, Boundless Bio Common has a negative expected return of -0.23%. Please make sure to confirm Boundless Bio's day median price, price action indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if Boundless Bio Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
Boundless Bio Common has very good reverse predictability. Overlapping area represents the amount of predictability between Boundless Bio time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio Common price movement. The serial correlation of -0.69 indicates that around 69.0% of current Boundless Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Boundless Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Boundless Bio Common Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Boundless Bio Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Boundless Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Boundless Bio Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Boundless Bio Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Boundless Bio Common price pattern first instead of the macroeconomic environment surrounding Boundless Bio Common. By analyzing Boundless Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Boundless Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Boundless Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
Boundless Bio January 24, 2026 Technical Indicators
Most technical analysis of Boundless help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Boundless from various momentum indicators to cycle indicators. When you analyze Boundless charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.56) | |||
| Mean Deviation | 2.12 | |||
| Coefficient Of Variation | (1,273) | |||
| Standard Deviation | 2.95 | |||
| Variance | 8.73 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.57) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 4.13 | |||
| Skewness | 0.8895 | |||
| Kurtosis | 3.04 |
Boundless Bio January 24, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Boundless stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.20) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 1.27 | ||
| Day Typical Price | 1.27 | ||
| Price Action Indicator | (0.02) | ||
| Market Facilitation Index | 0.05 |
Complementary Tools for Boundless Stock analysis
When running Boundless Bio's price analysis, check to measure Boundless Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio is operating at the current time. Most of Boundless Bio's value examination focuses on studying past and present price action to predict the probability of Boundless Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio's price. Additionally, you may evaluate how the addition of Boundless Bio to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |